Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction

被引:144
作者
Sun, J
Huang, SH
Tan, BKH
Whiteman, M
Zhu, YC
Wu, YJ
Ng, Y
Duan, W
Zhu, YZ
机构
[1] Natl Univ Singapore, Fac Med, Dept Pharmacol, Singapore 117548, Singapore
[2] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore
[3] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med,Dept Physiol & Pathophysiol, Shanghai 200032, Peoples R China
[4] Natl Univ Singapore, Dept Anat, Singapore 117548, Singapore
基金
英国医学研究理事会;
关键词
purified Salvia miltiorrhiza extract (PSME); myocardial infarction; Salvia miltiorrhiza; antioxidant; infarct size; ramipril;
D O I
10.1016/j.lfs.2004.11.016
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
In the current study, we compared purified Salvia miltiorrhiza extract (PSME) with Angiotensin-converting enzyme inhibitor, Ramipril, in in vitro experiments and also in vivo using animal model of myocardial infarction. PSME was found to have a significantly higher trolox equivalent antioxidant capacity which indicated a great capacity for scavenging free radicals. PSME could also prevent pyrogallo red bleaching and DNA damage. After 2 weeks treatment with PSME or Ramipril, survival rates of rats with experimental myocardial infarction were marginally increased (68.2% and 71.4%) compared with saline (61.5%). The ratios of infarct size to left ventricular size in both PSME-and Ramipril-treated rats were significantly less than that in the saline-treated group. Activity of cardiac antioxidant enzyme superoxide dismutase (SOD) was significant higher while level of Thiobarbituric acid-reactive substances (TBARs) was lower in the PSME treated group. Purified and standardized Chinese herb could provide an alternative regimen for the prevention of ischemic heart disease. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:2849 / 2860
页数:12
相关论文
共 20 条
[1]
ANVERSA P, 1993, CIRCULATION, V87, P22
[2]
Role of oxidative stress in cardiovascular diseases [J].
Dhalla, NS ;
Temsah, RM ;
Netticadan, T .
JOURNAL OF HYPERTENSION, 2000, 18 (06) :655-673
[3]
Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats [J].
Ji, XY ;
Tan, BKH ;
Zhu, YC ;
Linz, W ;
Zhu, YZ .
LIFE SCIENCES, 2003, 73 (11) :1413-1426
[4]
Ji XY, 2000, ACTA PHARMACOL SIN, V21, P1089
[5]
JI XY, 2004, NOVEL COMPOUNDS NATU, P151
[6]
Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction [J].
Linz, W ;
Itter, G ;
Dobrucki, LW ;
Malinski, T ;
Wiemer, G .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2003, 4 (03) :180-185
[7]
ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, LEFT-VENTRICULAR HYPERTROPHY AND FIBROSIS [J].
LINZ, W ;
WIEMER, G ;
SCHAPER, J ;
ZIMMERMANN, R ;
NAGASAWA, K ;
GOHLKE, P ;
UNGER, T ;
SCHOLKENS, BA .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 147 (1-2) :89-97
[8]
Long LH, 2001, METHOD ENZYMOL, V335, P181
[9]
MOCHIZUKI S, 1998, ISCHEMIC HEART
[10]
Role of oxidative stress in myocardial hypertrophy and failure [J].
Sawyer, DB ;
Siwik, DA ;
Xiao, L ;
Pimentel, DR ;
Singh, K ;
Colucci, WS .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (04) :379-388